(OLN) Olin - Overview
Sector: Basic Materials | Industry: Chemicals | Exchange: NYSE (USA) | Market Cap: 2.965m USD | Total Return: 32.9% in 12m
Avg Turnover: 58.1M
Qual. Beats: 0
Rev. Trend: -53.3%
Qual. Beats: 0
Warnings
High Debt/EBITDA (6.6) with thin interest coverage (0.0)
Interest Coverage Ratio 0.0 is critical
Below Avwap Earnings
Tailwinds
Confidence
Olin Corporation is a vertically integrated manufacturer specializing in three core segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester ammunition. The company produces essential industrial chemicals, including chlorine, caustic soda, and epoxy resins, alongside a broad range of small-caliber ammunition for military, law enforcement, and commercial markets. Headquartered in Clayton, Missouri, Olin maintains a global distribution network spanning North America, Europe, Asia Pacific, and Latin America.
Operating within the commodity chemicals sector, Olin’s profitability is heavily influenced by the electrochemical unit (ECU) pricing cycle, which tracks the combined value of chlorine and its co-product, caustic soda. The company utilizes a low-cost production model by leveraging significant scale and integrated supply chains to serve diverse end-markets ranging from construction and water treatment to national defense. For a deeper look into the companys historical valuation trends, consider reviewing the data on ValueRay.
- Caustic soda pricing and demand cycles dictate Chlor Alkali segment profitability
- Global epoxy resin oversupply and low demand compress industrial chemical margins
- Winchester ammunition sales fluctuate based on military contracts and consumer demand
- Raw material costs for ethylene and electricity impact overall manufacturing margins
- Regulatory shifts in chemical safety standards affect long-term operational costs and compliance
| Net Income: -127.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.50 > 1.0 |
| NWC/Revenue: 8.23% < 20% (prev 12.40%; Δ -4.17% < -1%) |
| CFO/TA 0.07 > 3% & CFO 511.6m > Net Income -127.0m |
| Net Debt (3.37b) to EBITDA (510.2m): 6.61 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (113.8m) vs 12m ago -2.40% < -2% |
| Gross Margin: 6.44% > 18% (prev 0.10%; Δ 633.3% > 0.5%) |
| Asset Turnover: 89.54% > 50% (prev 85.55%; Δ 3.99% > 0%) |
| Interest Coverage Ratio: 0.02 > 6 (EBITDA TTM 510.2m / Interest Expense TTM 183.0m) |
| A: 0.08 (Total Current Assets 2.10b - Total Current Liabilities 1.54b) / Total Assets 7.35b |
| B: 0.28 (Retained Earnings 2.03b / Total Assets 7.35b) |
| C: 0.00 (EBIT TTM 3.60m / Avg Total Assets 7.50b) |
| D: 0.31 (Book Value of Equity 1.73b / Total Liabilities 5.62b) |
| Altman-Z'' = 1.72 = BBB |
| DSRI: 0.79 (Receivables 915.4m/1.12b, Revenue 6.72b/6.55b) |
| GMI: 1.61 (GM 6.44% / 10.37%) |
| AQI: 1.01 (AQ_t 0.38 / AQ_t-1 0.37) |
| SGI: 1.03 (Revenue 6.72b / 6.55b) |
| TATA: -0.09 (NI -127.0m - CFO 511.6m) / TA 7.35b) |
| Beneish M = -2.71 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at USD 25.87 with a total of 2,482,768 shares traded.
Over the past week, the price has changed by -0.58%,
over one month by -4.84%,
over three months by +3.51% and
over the past year by +32.86%.
Olin has received a consensus analysts rating of 3.25. Therefore, it is recommended to hold OLN.
- StrongBuy: 3
- Buy: 0
- Hold: 12
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 29 | 12.1% |
P/E Forward = 42.735
P/S = 0.4412
P/B = 1.7095
P/EG = 7.0492
Revenue TTM = 6.72b USD
EBIT TTM = 3.60m USD
EBITDA TTM = 510.2m USD
Long Term Debt = 3.00b USD (from longTermDebt, last quarter)
Short Term Debt = 76.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.57b USD (from shortLongTermDebtTotal, last quarter) + Leases 314.8m
Net Debt = 3.37b USD (calculated: Debt 3.57b - CCE 192.2m)
Enterprise Value = 6.34b USD (2.96b + Debt 3.57b - CCE 192.2m)
Interest Coverage Ratio = 0.02 (Ebit TTM 3.60m / Interest Expense TTM 183.0m)
EV/FCF = 20.92x (Enterprise Value 6.34b / FCF TTM 303.0m)
FCF Yield = 4.78% (FCF TTM 303.0m / Enterprise Value 6.34b)
FCF Margin = 4.51% (FCF TTM 303.0m / Revenue TTM 6.72b)
Net Margin = -1.89% (Net Income TTM -127.0m / Revenue TTM 6.72b)
Gross Margin = 6.44% ((Revenue TTM 6.72b - Cost of Revenue TTM 6.29b) / Revenue TTM)
Gross Margin QoQ = 5.03% (prev 1.88%)
Tobins Q-Ratio = 0.86 (Enterprise Value 6.34b / Total Assets 7.35b)
Interest Expense / Debt = 5.13% (Interest Expense 183.0m / Debt 3.57b)
Taxrate = 21.0% (US default 21%)
NOPAT = 2.84m (EBIT 3.60m * (1 - 21.00%))
Current Ratio = 1.36 (Total Current Assets 2.10b / Total Current Liabilities 1.54b)
Debt / Equity = 2.06 (Debt 3.57b / totalStockholderEquity, last quarter 1.73b)
Debt / EBITDA = 6.61 (Net Debt 3.37b / EBITDA 510.2m)
Debt / FCF = 11.13 (Net Debt 3.37b / FCF TTM 303.0m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.69% (Net Income -127.0m / Total Assets 7.35b)
RoE = -6.73% (Net Income TTM -127.0m / Total Stockholder Equity 1.89b)
RoCE = 0.07% (EBIT 3.60m / Capital Employed (Equity 1.89b + L.T.Debt 3.00b))
RoIC = 0.05% (NOPAT 2.84m / Invested Capital 5.89b)
WACC = 6.99% (E(2.96b)/V(6.53b) * Re(10.52%) + D(3.57b)/V(6.53b) * Rd(5.13%) * (1-Tc(0.21)))
Discount Rate = 10.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -3.57%
[DCF] Terminal Value 77.97% ; FCFF base≈231.4m ; Y1≈265.3m ; Y5≈390.4m
[DCF] Fair Price = 21.97 (EV 5.87b - Net Debt 3.37b = Equity 2.50b / Shares 113.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.06 | # QB: 0
Revenue Correlation: -53.25 | Revenue CAGR: -3.10% | SUE: -0.52 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.09 | Chg30d=+200.58% | Revisions=+33% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.41 | Chg30d=+144.86% | Revisions=+33% | Analysts=5
EPS current Year (2026-12-31): EPS=0.31 | Chg30d=+142.36% | Revisions=+20% | GrowthEPS=+233.6% | GrowthRev=+3.3%
EPS next Year (2027-12-31): EPS=0.93 | Chg30d=+2.49% | Revisions=+33% | GrowthEPS=+201.8% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +33%